Opportunity Information: Apply for PAR 23 274
Apply for PAR 23 274
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2023-08-23.
- Applicants must submit their applications by 2026-11-19.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: OJJDP FY 2023 Invited to Apply - Juvenile Justice Facility Leadership Certificate Program Training and Technical Assistance
Previous opportunity: USAID Nepali Women in Business
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 274
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 274) also looked into and applied for these:
| Funding Opportunity |
|---|
| Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 046 Funding Number: RFA AG 24 046 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 162 Funding Number: RFA MH 24 162 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA AG 24 027 Funding Number: RFA AG 24 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional) Apply for RFA RM 23 012 Funding Number: RFA RM 23 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed) Apply for RFA HG 23 002 Funding Number: RFA HG 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional) Apply for RFA AG 24 031 Funding Number: RFA AG 24 031 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional) Apply for RFA AG 24 030 Funding Number: RFA AG 24 030 Agency: National Institutes of Health Category: Health Funding Amount: $2,750,000 |
| Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed) Apply for RFA DE 24 003 Funding Number: RFA DE 24 003 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed) Apply for PAR 22 268 Funding Number: PAR 22 268 Agency: National Institutes of Health Category: Health Funding Amount: $325,000 |
| Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 23 055 Funding Number: RFA AI 23 055 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Developing Salivary Components as Therapeutics for Oral Health (R01 Clinical Trial Not Allowed) Apply for RFA DE 24 004 Funding Number: RFA DE 24 004 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Developing Salivary Components as Therapeutics for Oral Health (R21 Clinical Trial Not Allowed) Apply for RFA DE 24 005 Funding Number: RFA DE 24 005 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed) Apply for RFA MH 25 145 Funding Number: RFA MH 25 145 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| IDeA Clinical and Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional) Apply for PAR 23 241 Funding Number: PAR 23 241 Agency: National Institutes of Health Category: Health Funding Amount: $1,300,000 |
| IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional) Apply for PAR 23 257 Funding Number: PAR 23 257 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional) Apply for RFA MH 25 125 Funding Number: RFA MH 25 125 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional) Apply for RFA MH 25 126 Funding Number: RFA MH 25 126 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed) Apply for RFA HL 24 015 Funding Number: RFA HL 24 015 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed) Apply for RFA HL 24 016 Funding Number: RFA HL 24 016 Agency: National Institutes of Health Category: Health Funding Amount: $1,260,000 |
| High-Priority Behavioral and Social Research Networks??(R24 Clinical Trial Optional) Apply for RFA AG 24 034 Funding Number: RFA AG 24 034 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 274", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.